Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
be microinjection of RNA and DNA into zebrafish embryos to assist in characterizing a tumor model of childhood central nervous system cancer. The candidate will screen fish for tumor formation, as
-
Offer Description About the research group The IDIBELL Animal Facility provides support to researchers who require the use of laboratory animals (mice, hamsters, and zebrafish) for their research projects
-
immune cell (neutrophils) culture and zebrafish models with the latest molecular biology, genomics, bioinformatics and in vivo imaging to investigate how ELAVL1, a major RNA-binding, impacts on immune cell
-
-class microscopy, cell biology, and zebrafish facilities that our institute offers. Moreover, the candidate is expected to make strong connections with the Drug Discovery research community in other
-
microinjection of RNA and DNA into zebrafish embryos to assist in characterizing a tumor model of childhood central nervous system cancer. The candidate will screen fish for tumor formation, as well as perform
-
in developmental biology, genetics, or related discipline, with strong postdoctoral research experience. Bring substantial hands-on expertise in vertebrate embryology, especially mouse, zebrafish
-
and lateral plate mesoderm using zebrafish and mice as models, as well as associated structural birth defects, such as spina bifida, or defects affecting the heart/blood/bone/kidney. We are further
-
Hereditary Diseases. Lab Website: https://researchgroups.uic.es/ironmetabolism/ Where to apply E-mail [email protected] Requirements Research FieldBiological sciences » BiologyEducation LevelMaster Degree
-
applies these discoveries to mammalian models of nervous system repair. Our research integrates zebrafish genetics, human iPSC-derived neuronal models, single-cell genomics, advanced imaging, and functional
-
Apply online now: https://karriere.klinikum.uni-heidelberg.de/index.php?ac=application&jobad_id=28154 PhD – Position (m/f/d) Therapeutic potential of dipeptides in diabetic vasculopathy and